ClinicalTrials.gg
RecruitingNCT07881445Updated Oct 19, 2026

Subchondral Drilling Diameter During CARTISTEM Implantation for Knee Cartilage Defects

An interventional study of 2-mm subchondral drilling and Sequential 4-mm and 2-mm subchondral drilling in Osteoarthritis, Knee and Articular Cartilage Defects of the Knee, sponsored by Yonsei University. Recruiting at 1 site in South Korea. Open to participants aged 19 Years and older. Per ClinicalTrials.gov, last updated 2026-10-19.

Sponsored by Yonsei University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Started Jul 2026; still recruiting 3 months later.
Updated Oct 19, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
19 Years and older
Sex
All
01

Study summary

This prospective, randomized study at Severance Hospital compares two subchondral drilling techniques during CARTISTEM implantation for symptomatic medial-compartment knee articular cartilage defects. Sixty participants will be allocated 1:1 to drilling with a 2-mm drill alone or sequential drilling with 4-mm and 2-mm drills. CARTISTEM preparation and implantation will be the same in both groups. High tibial osteotomy may be performed when needed to correct alignment.

The primary endpoint is the International Knee Documentation Committee (IKDC) Subjective Knee Evaluation score at 12 months after surgery. The study will assess non-inferiority of the 2-mm technique using a prespecified margin of 10.3 points. Secondary assessments include pain and knee function, MRI cartilage repair and subchondral bone findings, radiographic osteoarthritis and alignment, and second-look arthroscopy in participants undergoing plate removal after high tibial osteotomy.

Read the detailed description

Eligible adults with persistent knee pain and medial-compartment cartilage defects scheduled for CARTISTEM implantation will be recruited at the Department of Orthopedic Surgery, Severance Hospital. Computer-generated randomization will allocate 60 participants equally between two parallel groups. Recruitment is planned for one year, follow-up for 12 months after surgery, and the overall research period for three years after approval.

The experimental group will undergo subchondral drilling with a 2-mm drill alone. The active comparator group will undergo sequential drilling with 4-mm and 2-mm drills. Both groups will receive allogeneic human umbilical cord blood-derived mesenchymal stem cells mixed with sodium hyaluronate hydrogel and implanted into the drilled holes and over the cartilage defect. High tibial osteotomy may accompany implantation when clinically indicated.

Baseline assessments include demographics, clinical scores, standing knee radiographs, lower-limb alignment radiographs, and MRI. Arthroscopy at surgery will document lesion location, size, and ICRS lesion grade. IKDC, pain VAS, Lysholm, and KOOS assessments are scheduled at 3, 6, and 12 months. Radiographic assessments are scheduled at 6 and 12 months, and MRI at 12 months. Second-look arthroscopy is limited to participants undergoing plate removal after concomitant high tibial osteotomy.

Non-inferiority will be assessed using the between-group difference in the 12-month IKDC score and its 95% confidence interval, with a 10.3-point margin. Adverse events will be assessed at postoperative visits.

Participants are masked to the allocated drilling technique. Assessors of secondary imaging, arthroscopic, and histological outcomes are masked to allocation and evaluate coded participant information. The operating surgeon is aware of allocation. No biopsy or genetic analysis is planned.

Research funding: MEDIPOST; total study budget: KRW 60,000,000.

02

Conditions studied

  • Osteoarthritis, Knee
  • Articular Cartilage Defects of the Knee

Keywords

  • CARTISTEM
  • allogeneic umbilical cord blood-derived mesenchymal stem cells
  • subchondral drilling
  • cartilage repair
  • knee osteoarthritis
  • IKDC
  • MOCART 2.0
  • high tibial osteotomy
03

In context

Osteoarthritis, Knee

3,391 studies on the registry are indexed under Osteoarthritis, Knee; 628 are open to participants now.

This study's planned enrollment of 60 is below the median of 69 across 2,808 interventional studies indexed under Osteoarthritis, Knee.

Browse Osteoarthritis, Knee studies →

Lead sponsor

Yonsei University is the lead sponsor of 1,410 studies on the registry; 235 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
19 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Age 19 years or older.
  2. Knee pain for at least 3 months despite conservative treatment, including medication or physical therapy.
  3. Medial-compartment knee arthritis or articular cartilage defects judged to be the main cause of symptoms.
  4. Imaging-confirmed medial-compartment cartilage defects for which CARTISTEM implantation has been decided.
  5. Voluntary written informed consent by the participant or legally authorized representative after understanding the study.

Exclusion criteria

Exclusion Criteria:

  1. Surgery for knee cartilage injury within 1 year before screening.
  2. Ligament instability requiring simultaneous ligament surgery.
  3. Kellgren-Lawrence grade IV osteoarthritis on weight-bearing anteroposterior knee radiographs.
  4. Mechanical-axis varus deformity of 5 degrees or greater, unless corrected by simultaneous high tibial osteotomy.
  5. Autoimmune or inflammatory arthritis, including rheumatoid arthritis.
  6. Inability to undergo MRI.
  7. Body mass index of 35 kg/m² or greater.
  8. Inability to adequately understand the study explanation, including illiteracy or a language barrier.
  9. Age younger than 19 years.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
60 participants (estimated)

Study arms

  • Experimental
    2-mm subchondral drilling

    Subchondral drilling with a 2-mm drill alone, followed by CARTISTEM implantation. High tibial osteotomy may be performed when needed for alignment correction.

    Procedure: 2-mm subchondral drilling

  • Active comparator
    Sequential 4-mm and 2-mm subchondral drilling

    Sequential subchondral drilling with 4-mm and 2-mm drills, followed by the same CARTISTEM preparation and implantation. High tibial osteotomy may be performed when needed.

    Procedure: Sequential 4-mm and 2-mm subchondral drilling

Interventions

  • Procedure2-mm subchondral drilling

    Under general or spinal anesthesia, the cartilage defect is exposed and prepared. Subchondral holes are drilled with a 2-mm drill alone. Allogeneic umbilical cord blood-derived mesenchymal stem cells are mixed with sodium hyaluronate hydrogel, placed into the drilled holes, and applied over the defect. The same cell product preparation is used in both arms. High tibial osteotomy may precede implantation when indicated.

    Also known as: 2-mm subchondral drilling with CARTISTEM implantation, Small-diameter subchondral drilling, CARTISTEM implantation

  • ProcedureSequential 4-mm and 2-mm subchondral drilling

    Under general or spinal anesthesia, the cartilage defect is exposed and prepared. Subchondral holes are made using sequential 4-mm and 2-mm drilling. The same allogeneic umbilical cord blood-derived mesenchymal stem cell and sodium hyaluronate hydrogel preparation is implanted into the holes and over the defect. High tibial osteotomy may precede implantation when indicated.

    Also known as: Sequential 4-mm and 2-mm subchondral drilling with CARTISTEM implantation, Combined-diameter subchondral drilling; CARTISTEM implantation.

06

What researchers measure

Primary outcomes

  1. IKDC Subjective Knee Evaluation score at 12 months after surgery

    The IKDC Subjective Knee Evaluation score assesses participant-reported knee symptoms and function on a 0-100 scale. Higher scores indicate better function and fewer symptoms. The primary non-inferiority comparison uses the 12-month between-group difference and its 95% confidence interval, with a prespecified margin of 10.3 points.

    Time frame: 12 months after surgery. Additional protocol measurements occur at 3 and 6 months.

Secondary outcomes

  1. Pain visual analog scale

    Knee pain assessed using a 10-cm visual analog scale (VAS), recorded from 0 to 10: 0 = no pain; 10 = worst imaginable pain. Higher scores indicate greater pain. Scores and changes from baseline are assessed.

    Time frame: Baseline and 3, 6, and 12 months after surgery

  2. Lysholm knee score

    Patient-reported knee symptoms and function measured using the Lysholm knee score, ranging from 0 to 100; higher scores indicate better knee function.

    Time frame: Baseline and 3, 6, and 12 months after surgery

  3. Knee injury and Osteoarthritis Outcome Score (KOOS)

    The original 42-item Knee injury and Osteoarthritis Outcome Score (KOOS) assesses pain, symptoms, activities of daily living, sport/recreation, and knee-related quality of life. Each of the five subscales is scored separately from 0 to 100; higher scores indicate fewer symptoms and better function.

    Time frame: Baseline and 3, 6, and 12 months after surgery

  4. MOCART 2.0 knee score

    MRI assessment of cartilage repair using the MOCART 2.0 knee score, ranging from 0 to 100; higher scores indicate more favorable repair tissue morphology.

    Time frame: 12 months after surgery

  5. Subchondral edema assessment

    Subchondral edema assessed on MRI using the relevant MOCART 2.0 subscale.

    Time frame: 12 months after surgery

  6. Presence of subchondral cysts

    Presence or absence of subchondral cysts on MRI.

    Time frame: 12 months after surgery

  7. Presence of subchondral insufficiency fracture

    Presence or absence of subchondral insufficiency fracture on MRI.

    Time frame: 12 months after surgery

  8. ICRS Cartilage Repair Assessment

    ICRS Cartilage Repair Assessment at second-look arthroscopy during plate removal in participants with concomitant high tibial osteotomy. Defect filling, integration with adjacent cartilage, and macroscopic appearance are each scored from 0 to 4 and summed to a total of 0 to 12; higher scores indicate better cartilage repair. Overall repair is classified from Grade I (normal) to Grade IV (severely abnormal).

    Time frame: At second-look arthroscopy during plate removal, planned at 12 months

  9. Kellgren-Lawrence grade

    Radiographic osteoarthritis assessed using the Kellgren-Lawrence grade, ranging from 0 to 4; higher grades indicate more severe osteoarthritis.

    Time frame: Baseline and 6 and 12 months after surgery

  10. Hip-knee-ankle angle

    Lower-limb alignment measured as the hip-knee-ankle angle, in degrees, on standing full-length radiographs.

    Time frame: Baseline and 6 and 12 months after surgery

07

Study locations

1 of 1 sites recruiting
  • Yonsei University College of Medicine
    Seoul, South Korea
    Recruiting
08

References and documents

Individual participant data

Plan to share: Undecided — The plan to share individual participant data with other researchers has not yet been determined.

No publications or documents are linked to this record.

09

Updates

1 registry update since Sep 25, 2026
Registered
First appeared on the registry. No changes since
Oct 19, 2026
Show all 1 update
  1. Oct 19, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07881445
Lead sponsor
Yonsei University
Responsible party
Sponsor
First posted
Oct 19, 2026
Start date
Jul 13, 2026
Primary completion
Jul 31, 2028 (estimated)
Completion
Feb 19, 2029 (estimated)
Last update
Oct 19, 2026

Study contacts

Sung-Hwan Kim, Professor
Contact
orthohwan@gmail.com
+82-2-2228-2180

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion